FOR-6219

Forendo Pharma Ltd · Phase 1 active Small molecule

At a glance

Generic name	FOR-6219
Sponsor	Forendo Pharma Ltd
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

FOR-6219 CI brief — competitive landscape report
FOR-6219 updates RSS · CI watch RSS
Forendo Pharma Ltd portfolio CI